Jupiter Asset Management Ltd. Acquires 184,834 Shares of Option Care Health, Inc. $OPCH

Jupiter Asset Management Ltd. raised its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 35.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 708,742 shares of the company’s stock after purchasing an additional 184,834 shares during the quarter. Jupiter Asset Management Ltd.’s holdings in Option Care Health were worth $22,581,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in OPCH. Durable Capital Partners LP lifted its position in shares of Option Care Health by 134.2% during the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after purchasing an additional 4,720,988 shares during the last quarter. UBS Group AG lifted its position in shares of Option Care Health by 250.2% during the third quarter. UBS Group AG now owns 1,165,525 shares of the company’s stock worth $32,355,000 after purchasing an additional 832,720 shares during the last quarter. Alliancebernstein L.P. lifted its position in shares of Option Care Health by 113.6% during the third quarter. Alliancebernstein L.P. now owns 1,298,691 shares of the company’s stock worth $36,052,000 after purchasing an additional 690,572 shares during the last quarter. Duquesne Family Office LLC purchased a new position in shares of Option Care Health during the second quarter valued at $20,685,000. Finally, Arrowstreet Capital Limited Partnership increased its stake in shares of Option Care Health by 17.3% during the third quarter. Arrowstreet Capital Limited Partnership now owns 4,001,307 shares of the company’s stock valued at $111,076,000 after buying an additional 590,913 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Option Care Health

In related news, CEO John Charles Rademacher bought 12,500 shares of the business’s stock in a transaction on Monday, May 4th. The shares were bought at an average price of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the purchase, the chief executive officer directly owned 695,152 shares of the company’s stock, valued at approximately $14,723,319.36. This trade represents a 1.83% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,610 shares of the business’s stock in a transaction on Monday, May 4th. The stock was bought at an average price of $21.41 per share, for a total transaction of $783,820.10. Following the purchase, the director directly owned 450,000 shares of the company’s stock, valued at $9,634,500. The trade was a 8.86% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased 73,264 shares of company stock worth $1,548,316 over the last quarter. Insiders own 1.70% of the company’s stock.

Option Care Health Stock Performance

Shares of Option Care Health stock opened at $20.87 on Friday. The stock’s fifty day moving average price is $25.13 and its 200-day moving average price is $29.82. Option Care Health, Inc. has a 12 month low of $18.01 and a 12 month high of $36.80. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85. The firm has a market cap of $3.28 billion, a P/E ratio of 16.18, a P/E/G ratio of 1.20 and a beta of 0.68.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. During the same quarter in the previous year, the firm earned $0.40 earnings per share. The firm’s quarterly revenue was up 1.3% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, equities research analysts expect that Option Care Health, Inc. will post 1.64 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently commented on OPCH. Zacks Research lowered Option Care Health from a “hold” rating to a “strong sell” rating in a research note on Monday, May 11th. UBS Group cut their price target on Option Care Health from $45.00 to $39.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Stephens set a $30.00 price target on Option Care Health in a research note on Friday, May 1st. TD Cowen cut their price target on Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a research note on Friday, May 1st. Finally, Barrington Research cut their price target on Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Option Care Health currently has a consensus rating of “Moderate Buy” and an average price target of $31.25.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.